Skip to main content
. Author manuscript; available in PMC: 2016 Jun 3.
Published in final edited form as: Prog Neuropsychopharmacol Biol Psychiatry. 2015 Jan 17;59:40–48. doi: 10.1016/j.pnpbp.2015.01.009

Table 1.

Demographics and drug use.

Nepicastat (n = 15) Placebo (n = 5)
Gender (n)
  Male 13 4
  Female 2 1
Race/ethnicity (n)
  Caucasian 7 2
  Hispanic 1 0
  African American 7 3
Age (years) 40.46 ± 1.3 37.8 ± 2.2
Education (years) 11.90 ± 0.2 12.2 ± 0.2
Cocaine use
  Years of use 16.9 ± 1.9 16.8 ± 2.9
  Last 30 days usea 22.5 ± 1.2 26.4 ± 2.8
Cocaine primary route of admin (n)
  Smoke 13 5
  IV 2 0
Alcohol use (n) 15/15 5/5
  Years of use 15.1 ± 2.1 15.6 ± 5.7
  Last 30 days use 10.1 ± 2.4 17.8 ± 7.3
Marijuana use (n) 13/15 4/5
  Years of use 12.4 ± 2.7 13.2 ± 4.6
  Last 30 days use 7.2 ± 2.7 9.4 ± 6.6

Data reflect number of subjects (n) or mean ± S.E.M.

a

Last 30 days use reflected the 30 days preceding screening for the current study.